首页> 外文期刊>International archives of allergy and immunology >Negativity of the basophil activation test in quinolone hypersensitivity: A breakthrough for provocation test decision-making
【24h】

Negativity of the basophil activation test in quinolone hypersensitivity: A breakthrough for provocation test decision-making

机译:喹诺酮类超敏反应中嗜碱性粒细胞活化试验的阴性:激发试验决策的突破

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Quinolone hypersensitivity reactions are being more frequently reported. Skin tests in investigations of patients are known to not be fully reliable. The provocation test thus remains the gold standard in the definitive diagnosis of allergy, despite the risks involved. The aim of this study was to evaluate basophil activation tests (BATs) in the diagnosis of immediate-type reactions to quinolones. Methods: Thirty-four patients who presented an immediate-type hypersensivity reaction less than an hour after quinolone administration were studied. The allergologic workup of these patients consisted of a careful clinical history, a skin test and a BAT with the culprit quinolone. If not contraindicated, and in the case of high probability of a nonallergic reaction, provocation tests were performed to assess the nonimmunologic nature of the hypersensitivity. Results: Among the 34 patients studied, 17 (50%) presented a negative BAT to the suspected quinolone, while the other 17 (50%) patients presented a positive BAT for quinolone at the time of their reaction. Among the 17 patients with negative BATs, 15 (2 of whom had had positive skin tests) had quinolone success- fully reintroduced. Conclusions: Our report suggests that the BAT, if negative for the culprit quinolone, is a valuable tool in the decision whether or not to perform provocation tests in patients with a history of immediate-type reaction to quinolones, in order to exclude an allergic reaction.
机译:背景:喹诺酮类超敏反应被更频繁地报道。已知在患者调查中的皮肤测试并非完全可靠。因此,尽管存在风险,但激发试验仍是确诊过敏的金标准。这项研究的目的是评估嗜碱性粒细胞活化试验(BATs)在诊断喹诺酮类立即反应中的作用。方法:研究了34例在喹诺酮类药物给药后不到一个小时出现立即型超敏反应的患者。这些患者的变应性检查包括仔细的临床病史,皮肤试验和使用罪魁祸首喹诺酮的BAT。如果没有禁忌,并且在非过敏反应的可能性很高的情况下,进行激发试验以评估超敏反应的非免疫性质。结果:在研究的34例患者中,有17例(50%)对可疑喹诺酮类药物呈阴性BAT,而其他17例(50%)患者在反应时对喹诺酮类药物呈阳性BAT。在17例BAT阴性的患者中,有15例(其中2例的皮肤试验阳性)完全成功地重新引入了喹诺酮。结论:我们的报告表明,如果对罪魁祸首喹诺酮呈阴性,则BAT是决定是否对有喹诺酮类立即反应史的患者进行激发试验以排除过敏反应的有价值的工具。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号